Join the club for FREE to access the whole archive and other member benefits.

Senior UCLA scientists public states aim to fight aging to impact numerous diseases

Great to see the concept of reversing aging becoming a mainstream ambition - it hasn't always been that way!

24-Mar-2022

Key points from article :

Dr. Ming Guo says that she wants to reverse the aging process.

She is professor of neurology, molecular and medical pharmacology at the David Geffen School of Medicine at UCLA.

“If we could pause, delay or even reverse aging, we would make a significant impact against numerous diseases,” said Guo.

The percentage of people with Alzheimer's doubles every five years after the age of 65.

Guo joined the UCLA faculty two decades ago.

In a landmark publication in 2006, Guo and her team examined two genes, PINK1 and PARKIN, that are mutated in some people with Parkinson’s disease.

They discovered that the two genes work together to control the quality of mitochondria.

Dysfunctional mitochondria are associated with other neurodegenerative diseases, cancer, diabetes and heart disease.

UCLA to establish a new interdisciplinary center, led by Guo, that will focus on aging, mitochondrial health and dementia.

The new center also will be aligned with the California NanoSystems Institute (CNSI) at UCLA.

One of Guo’s newest areas of study is exploring PINK1 and PARKIN signaling in the gut.

Mentioned in this article:

Click on resource name for more details.

David Geffen School of Medicine at UCLA

Accredited medical school at UCLA.

Ming Guo

Professor of neurology, molecular and medical pharmacology at the David Geffen School of Medicine at UCLA

Topics mentioned on this page:
Ageing Research, Mitochondria